Advertisement
Screener

BML Capital Management, LLC Historic Quarter Change: USA Other Stocks, Reduced

BML Capital Management, LLC historic quarter change: USA Other Stocks, Reduced

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, BML Capital Management, LLC opened 8 positions, added to 13, reduced 6 and sold out of 23.

  • Q2 2025: Stock ELEVATION ONCOLOGY INC; Country of operation United States; Class COM; Shares before 5,890,934.
  • Q4 2024: Stock ALLOVIR INC; Country of operation United States; Class COM; Shares before 603,086.
  • Q4 2024: Stock NEXTCURE INC; Country of operation United States; Class COM; Shares before 276,465.
  • Q4 2024: Stock VERRICA PHARMACEUTICALS INC; Country of operation United States; Class COM; Shares before 180,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1616824), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-07); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-06); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-03); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-10); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-07); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-07); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-05); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-07); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-24). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2022-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025ELEVATION ONCOLOGY INC
CUSIP 28623U101
United StatesCOM5,890,9345,890,434-500$1,526,341$2,162,378+$636,0372025-08-11
Q4 2024ALLOVIR INC
CUSIP 019818103
United StatesCOM603,086184,246-418,840$487,595$77,383-$410,2122025-02-07
Q4 2024NEXTCURE INC
CUSIP 65343E108
United StatesCOM276,465273,536-2,929$378,757$210,896-$167,8612025-02-07
Q4 2024VERRICA PHARMACEUTICALS INC
CUSIP 92511W108
United StatesCOM180,000174,651-5,349$261,000$122,256-$138,7442025-02-07
Q2 2024NEXTCURE INC
CUSIP 65343E108
United StatesCOM306,465276,465-30,000$683,417$439,579-$243,8382024-08-07
Q1 2024ATHIRA PHARMA INC
CUSIP 04746L104
United StatesCOM1,454,362900,000-554,362$3,534,100$2,466,000-$1,068,1002024-04-24

Similar Firms

Firm NameCountry13F ValueHoldings
ACCREDITED INVESTOR SERVICES, LLCUnited States$0.156B77
BNB Wealth Management, LLCUnited States$0.156B90
Truxt Investmentos Ltda.Brazil$0.156B32
Cornerstone Financial Group, LLC /NE/United States$0.156B73
Invera Wealth Advisors, LLCUnited States$0.156B98
WINEBRENNER CAPITAL MANAGEMENT LLCUnited States$0.156B139
Adirondack Capital Advisors, LLCUnited States$0.156B44
Pioneer Family Office, LLCUnited States$0.156B122
Hidden Cove Wealth Management, LLCUnited States$0.156B109
BLUEFIN CAPITAL MANAGEMENT, LLCUnited States$0.156B127